Alnylam Pharmaceuticals
ALNY
#865
Rank
โ‚น2.802 T
Marketcap
โ‚น20,944
Share price
0.27%
Change (1 day)
-44.97%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company